The neuroprotective effects of the Wlds gene are correlated with proteasome expression rather than apoptosis

European Journal of Neuroscience

Volumn 25, Issue 8, 2007, Pages 2269-2274

  Simonin, Yannick ^a   Ferrer Alcon, Marcelino ^a   Ferri, Anna ^a   Kato, Ann C ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Apoptosis; Axons; Motoneurons; pmn; Proteasome; Wlds

Indexed keywords

PROTEASOME; BAX PROTEIN, MOUSE; CASPASE 3; NERVE PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; WLD PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE; GENE FUNCTION; GENETIC CORRELATION; MOUSE; NERVE CELL NECROSIS; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLOW WALLERIAN DEGENERATION GENE; SPINAL CORD MOTONEURON; ANIMAL; C57BL MOUSE; CYTOLOGY; GENETICS; METABOLISM; MOTONEURON; MOUSE STRAIN; NICK END LABELING; PATHOLOGY; PERIPHERAL NEUROPATHY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MOTOR NEURONS; NERVE TISSUE PROTEINS; PERIPHERAL NERVOUS SYSTEM DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 34247195153     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05501.x     Document Type: Article

References (27)

1. Araki, T., Sasaki, Y. & Milbrandt, J. (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science, 305, 1010-1013.
2. Bommel, H., Xie, G., Rossoll, W., Wiese, S., Jablonka, S., Boehm, T. & Sentdner, M. (2002) Missense mutation in the tubulin-specific chaperone E (Tbce) gene in the mouse mutant progressive motor neuronopathy, a model of human motoneuron disease. J. Cell. Biol., 159, 563-569.
3. Ciechanover, A. & Brundin, P. (2003) The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron, 40, 427-446.
4. Coleman, M. (2005) Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci., 6, 889-898.
5. Coleman, M.P. & Ribchester, R.R. (2004) Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system. Curr. Drug Targets CNS Neurol. Disord., 3, 227-238.
6. Ferri, A., Sanes, J.R., Coleman, M.P., Cunningham, J.M. & Kato, A.C. (2003) Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr. Biol., 13, 669-673.
7. Finn, J.T., Weil, M., Archer, F., Siman, R., Srinivasan, A. & Raff, M.C. (2000) Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J. Neurosci., 20, 1333-1341.
8. Kabashi, E., Agar, J.N., Taylor, D.M., Minotti, S. & Durham, H.D. (2004) Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis. J. Neurochem., 89, 1325-1335.
9. Laser, H., Mack, T.G., Wagner, D. & Coleman, M.P. (2003) Proteasome inhibition arrests neurite outgrowth and causes 'dying-back' degeneration in primary culture. J. Neurosci. Res., 74, 906-916.
10. Laser, H., Conforti, L., Morreale, G., Mack, T.G., Heyer, M., Haley, J.E., Wishart, T.M., Beirowski, B., Walker, S.A., Haase, S., Celik, A., Adalbert, R., Wagner, D., Grumme, D., Ribchester, R.R., Plomann, M. & Coleman, M.P. (2006) The slow wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus. Mol. Biol. Cell, 3, 1075-1084.
11. Li, M., Ona, V.O., Guegan, C., Chen, M., Jackson-Lewis, V., Andrews, L.J., Olszewski, A.J., Stieg, P.E., Lee, J.P., Przedborski, S. & Friedlander, R.M. (2000) Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science, 288, 335-339.
12. Lindsten, K., Menendez-Benito, V., Masucci, M.G. & Dantuma, N.P. (2003) A transgenic mouse model of the ubiquitin/proteasome system. Nat. Biotechnol., 21, 897-902.
13. Lunn, E.R., Perry, V.H., Brown, M.C., Rosen, H. & Gordon, S. (1989) Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci., 1, 27-33.
14. Mack, T.G., Reiner, M., Beirowski, B., Mi, W., Emanuelli, M., Wagner, D., Thomson, D., Gillingwater, T., Court, F., Conforti, L., Fernando, F.S., Tarlton, A., Andressen, C., Addicks, K., Magni, G., Ribchester, R.R., Perry, V.H. & Coleman, M.P. (2001) Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci., 4, 1199-1206.
15. Martin, N., Jaubert, J., Gounon, P., Salido, E., Haase, G., Szatanik, M. & Guenet, J.L. (2002) A missense mutation in Tbce causes progressive motor neuronopathy in mice. Nat. Genet., 32, 443-447.
16. Oh, Y.K., Shin, K.S. & Kang, S.J. (2006) AIF translocates to the nucleus in the spinal motor neurons in a mouse model of ALS. Neurosci. Lett., 406, 205-210.
17. Pasinelli, P., Houseweart, M.K., Brown, R.H. Jr & Cleveland, D.W. (2000) Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA, 97, 13901-13906.
18. Perrin, F.E., Boisset, G., Lathuiliere, A. & Kato, A.C. (2006) Cell death pathways differ in several mouse models with motoneurone disease: analysis of pure motoneurone populations at a presymptomatic age. J. Neurochem., 98, 1959-1972.
19. Perry, V.H., Brown, M.C. & Lunn, E.R. (1991) Very slow retrograde and Wallerian degeneration in the CNS of C57BL/Ola mice. Eur. J. Neurosci., 1, 102-105.
20. Perry, V.H., Brown, M.C., Lunn, E.R., Tree, P. & Gordon, S. (1990) Evidence that very slow Wallerian degeneration in C57BL/Ola mice is an intrinsic property of the peripheral nerve. Eur. J. Neurosci., 9, 802-808.
21. Sagot, Y., Dubois-Dauphin, M., Tan, S.A., de Bilbao, F., Aebischer, P., Martinou, J.C. & Kato, A.C. (1995) Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J. Neurosci., 5, 7727-7733.
22. Schmalbruch, H., Jensen, H.J., Bjaerg, M., Kamieniecka, Z. & Kurland, L. (1991) A new mouse mutant with progressive motor neuronopathy. J. Neuropathol. Ex. Neurol., 50, 192-204.
23. Vila, M. & Przedborski, S. (2003) Targeting programmed cell death in neurodegenerative diseases. Nat. Rev. Neurosci., 4, 365-375.
24. Vukosavic, S., Stefanis, L., Jackson-Lewis, V., Guegan, C., Romero, N., Chen, C., Dubois-Dauphin, M. & Przedborski, S. (2000) Delaying caspase activation by Bcl-2: a clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci., 20, 9119-9125.
25. Wang, J., Zhai, Q., Chen, Y., Lin, E., Gu, W., McBurney, M.W. & He, Z. (2005) A local mechanism mediates NAD-dependent protection of axon degeneration. J. Cell. Biol., 170, 349-355.
26. Whitmore, A.V., Lindsten, T., Raff, M.C. & Thompson, C.B. (2003) The proapoptotic proteins Bax and Bak are not involved in Wallerian degeneration. Cell. Death Differ., 10, 260-261.
27. Zhai, Q., Wang, J., Kim, A., Liu, Q., Watts, R., Hoopfer, E., Mitchison, T., Luo, L. & He, Z. (2003) Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron, 39, 217-225.